top
Search terms
Results 1 - 2 of 2 - ordered by :
Escardio

(1-3) Professor Philippe Gabriel Steg, principal investigator of the CLARIFY registry, said: “The optimal blood pressure target in patients with hypertension continues to be debated, especially ...

Date : 30/08/2016
Escardio

OSLER-1 and OSLER-2 Clinical Trials Evolocumab, a monoclonal antibody that inhibits pro-protein convertase subtilisin-kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) ...

Date : 21/10/2015